عنوان

Drugs between research and regulations :

شابک

3642541305

شابک

3642541321

شابک

9783642541308

شابک

9783642541322

شماره

b570066

عنوان اصلي

Drugs between research and regulations :

نام عام مواد

[Book]

ساير اطلاعات عنواني

proceedings of the 5th International Meeting of Pharmaceutical Physicians, Munich, October 14-17, 1984

نام نخستين پديدآور

C. Steichele, U. Abshagen, J. Koch-Weser (eds.) ; with the collaboration of D. Lorke [and others].

محل نشرو پخش و غیره

Darmstadt

نام ناشر، پخش کننده و غيره

Steinkopff Verlag ; New York : Springer-Verlag

تاریخ نشرو بخش و غیره

©1985.

نام خاص و کميت اثر

(xii, 205 pages) : illustrations

متن يادداشت

In memoriam Franz Gross--Preliminary page.

متن يادداشت

Chronic Concern on Chronic Toxicity Studies --; Chronic toxicity tests, current problems and possible solutions --; What can be gained from a retrospective analysis of chronic toxicity studies? --; The role of carcinogenicity studies in risk assessment --; Alternatives to chronic toxicity studies --; Clinical Trials and Medical Practice --; What good are clinical trials? --; Clinical guidelines --; a help or a hindrance? --; Clinical trials in the natural environment --; Clinical trials and the general practitioner --; Clinical trials and chronic diseases --; Alternatives to clinical trials in post-marketing research on drug effects --; The Future of Long-Term Intervention and Prevention Studies --; The future of long-term intervention and prevention studies --; methodological aspects --; Lessons for the future from long-term studies with beta blockers and hypolipidaemic agents --; Rauwolfia derivatives and breast cancer: how do we know when we have the answers? --; The organisation of long-term intervention and prevention studies --; New Biostatical Concepts for Clinical Trials --; The explanatory and pragmatic approaches in clinical trials --; Alternatives to classical randomized trials --; Data quality assurance with particular regard to protocol violations --; Clinical Trials in Children --; The need of clinical drug trials in children --; Ethical restrictions in clinical trials in children --; European Drug Registration --; The role of the EEC in the harmonisation of drug registration --; Clinical trials --; European recommendations --; Special Lecture --; The Pharmaceutical Industry --; research and responsibility.

متن يادداشت

Franz Gross died suddenly during preparations for the meeting. He would have taken great pleasure in summarizing in this preface the aims and results of a gathering which so clearly bore his imprint as Chairman of the Scientific Program Committee. His sudden passing away is deeply regretted by all of us: organizers, speakers and participants. We greatly respect him for his exceptional abilities, his impact on science and his qualities as a human being. He provided the impulse for a well balanced and topical scientific program. We therefore dedicate the proceedings of this symposium to his memory. Munich was the fifth in a traditional line of international meetings of pharmaceutical physicians held at three-year intervals, starting in London in 1972 ('International Aspects of Drug Evaluation and Usage'), and followed by Florence in 1975 (, Rationality of Drug Development'), Brussels in 1978 (, Pharmaceutical Medicine - the Future') and Paris in 1981 ('Drug Safety -;- Progress and Controversies'). This 5th meeting discussed improvements in drug development and application and examined the impact of regulatory activities.

موضوع مستند نشده

Drugs -- Testing -- Congresses.

موضوع مستند نشده

Drugs -- Toxicology -- Congresses.

موضوع مستند نشده

Pharmacokinetics -- Congresses.

شماره رده

نشانه اثر

مستند نام اشخاص تاييد نشده

C. Steichele, U. Abshagen, J. Koch-Weser (eds.) ; with the collaboration of D. Lorke [and others].

مستند نام اشخاص تاييد نشده

C Steichele

مستند نام اشخاص تاييد نشده

D Lorke

مستند نام اشخاص تاييد نشده

F H Gross

مستند نام اشخاص تاييد نشده

J Koch-Weser

مستند نام اشخاص تاييد نشده

U Abshagen

نام الکترونيکي

نوع ماده

[Book]

تكميل شده

Y